Abstract:A major antimicrobial resistance mechanism in Gram-negative bacteria is the production of β-lactamase enzymes. The increasing emergence of β-lactamase-producing multi-drug-resistant "superbugs" has resulted in increases in costly hospital Emergency Department (ED) visits and hospitalizations due to the requirement for parenteral antibiotic therapy for infections caused by these difficult-to-treat bacteria. To address the lack of outpatient treatment, we initiated an iterative program combining medicinal chemistry, biochemical testing, microbiological profiling, and evaluation of oral pharmacokinetics. Lead optimization focusing on multiple smaller, more lipophilic active compounds, followed by an exploration of oral bioavailability of a variety of their respective prodrugs, provided 36 (VNRX-7145/VNRX-5236 etzadroxil), the prodrug of the boronic acid-containing β-lactamase inhibitor 5 (VNRX-5236). In vitro and in vivo studies demonstrated that 5 restored the activity of the oral cephalosporin antibiotic ceftibuten against Enterobacterales expressing Ambler class A extended-spectrum β-lactamases, class A carbapenemases, class C cephalosporinases, and class D oxacillinases.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00437?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00437</a>.Inhibition assays, antimicrobial susceptibility testing, PK screening studies, mouse PK studies, metabolic stability, metabolite profiling, bidirectional permeability through Caco-2 monolayers, mouse efficacy study, HPLC method and HPLC of compounds 5 and 36, and 1H NMR of compounds 5 and 36 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00437/suppl_file/jm1c00437_si_002.pdf">PDF</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00437/suppl_file/jm1c00437_si_001.csv">CSV</a>)This article has not yet been cited by other publications.

The Synthesis of New Veterinary Drug Valnemulin Hydrochloride

Improved Synthetic Process for 3-Benzyloxy-4-n-butylaniline Hydrochloride

Synthesis technology of 3-n-propyl-2, 4-dihydroxyacetophenone

MICROSYNTHESIS OF A NOVEL HERBICIDE, PROPYL 4-[ 2-[ (4,6-DIMETHOXY-2-PYRIMIDINYL) OXY] BENZYLAMINO] BENZOATE

Review of Total Synthesis of Valienamine

MICROSYNTHESIS OF INSECTICIDAL COMPONENT 6β-PROPOXYCELANGULIN V

Synthesis of N-Methyl-4-aminobenzyl Sulfonamide

Diastereospecific epoxidation and highly regioselective ring-opening of (+)-valienamine: Practical synthesis of (+)-valiolamine

Production of antibodies and development of enzyme-linked immunosorbent assay for valnemulin in porcine liver

Synthesis of a New Antihyperlipidaemic Agent-Simvastatin

Synthesis, Characterization, and Biological Evaluation of Novel N-{4-[(4-Bromophenyl)sulfonyl]benzoyl}-L-valine Derivatives

Chemical Upcycling of Expired Pharmaceuticals as a Source of Value-Added Chemicals for Organic Synthesis and Medicinal Chemistry

A new synthesis of the amine fragment: an important intermediate to the anti-HIV drug lenacapavir

Synthesis and Properties of a New Water-Soluble Prodrug of the Adenosine A2A Receptor Antagonist MSX-2

The Optimization of the Synthesis Process and the Identification of Levobupivacaine Hydrochloride

Ex Vivo Pharmacokinetic/pharmacodynamic Relationship of Valnemulin Against Clostridium Perfringens in Plasma, the Small Intestinal and Caecal Contents of Rabbits.

Determining the fatty acids, polar and non-polar volatile organic compounds of the veterinary preparation “Trametin Plus”

Synthesis of the Antimicrobial Peptide Murepavadin Using Novel Coupling Agents

Synthesis and Biological Evaluation of New N-Acyl-α-amino Ketones and 1,3-Oxazoles Derivatives

Design, Synthesis and Biological Evaluation of Novel Pleuromutilin Derivatives Containing 6-Chloro-1-R-1H-pyrazolo[3,4-d]pyrimidine-4-amino Side Chain

Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes